ECRIN (European Clinical Research Infrastructure Network)

We are very excited to announce the launch of our International Clinical Trials Day (ICTD) for 2025. We are co-hosting with our Spanish partner Spanish Clinical Research Network (SCReN) to bring you what we hope to be a very insightful day. 📆Date: Tuesday, 20 May, 2025 📍 Place: Madrid, Spain 👩🔬 Theme: Rethinking Clinical Trials: Inclusivity in Practice The need for greater inclusivity in clinical trials is clear in Europe and there is an increasing obligation to progress from discussion to concrete implementation. By uniting different stakeholders from the community, ICTD will shed light not only on why diversity, equity and inclusion should be embraced in clinical research but will give concrete examples of what has been done so far and where there are still hurdles to overcome. More information will be released soon. For now, please mark the date in your diaries. We hope you are able to join us! 🌟 https://lnkd.in/e_mfQNxM #ClinicalTrials #DEI #ICTD #ICTD2025 CZECRIN, Infrastructure F-CRIN, KKS-Netzwerk e. V., HRB National Clinical Trials Office (NCTO), HECRIN (Hungarian National Health Research Agency) GreCRIN _ECRIN, ItaCRIN (Istituto Superiore di Sanità), NorCRIN, PCTN (Agencja Badań Medycznych), PtCRIN Portuguese Clinical Research Infrastructure Network, Spanish Clinical Research Network (SCReN), SLOVACRIN, Swiss Clinical Trial Organisation

ECRIN was thrilled to participate in the ERIC Forum Annual Meeting & Project Meeting in Brussels on 28–29 January! Maria Alexandra Rujano, ECRIN Project Manager, presented the ongoing work within ERIC Forum 2 to enhance key stakeholder engagement - crucial for advancing the integration of ERICs across all Horizon Europe pillars and strengthening Research Infrastructures' position in the European Research Area. A big thank you to BBMRI-ERIC for organizing this fantastic meeting and to all ERICs for the great collaboration in this project. Looking forward to continuing this important work together

We're incredibly happy to be mentioned by HNN 3.0, who have just launched their new tool.🔧 Just to also mention our Hungarian partners: https://lnkd.in/eCxkBsbi, who have also contributed! #ClinicalStudies #Tools

Calling all clinical triallists of the future! 🌍 Training is necessary for the facilitation of high-quality academic research and there is currently very little out there for students across Europe. 💻 In this video, Project Coordinator Jitka Rychlíčková explains what learners can expect from the training: “Through a practice-based curriculum, the impact of the project is to support academic clinical trials to increase the amount of investigator-initiated trials.”  Watch the full video: https://lnkd.in/gG2eYBSK  🔗 Discover CONSCIOUS-II today: https://lnkd.in/e5tkE283 #CONSCIOUSII #ClinicalStudies #PhD #Training National Partners: Masaryk University Brno, University of Pécs (Hungary), University of Szeged (Hungary), Universidade Nova de Lisboa (Portugal), Université Paris Cité (France), University College Cork UCC (Ireland) Associate partner: ECRIN (European Clinical Research Infrastructure Network) 

📣REMEDi4ALL is hosting a 3-part webinar series designed to explore and demystify clinical trials.📣 🗓️21 February, 28 February and 7 March 🕜12:30-13:30 CET 🌐Online (free) Mark your calendars to discuss clinical trials with REMEDi4ALL's partners Beacon for Rare Diseases, EURORDIS-Rare Diseases Europe and ECRIN (European Clinical Research Infrastructure Network). The webinar series will provide valuable insights into the purpose, process, and people behind clinical research, answering some of the most common questions raised by trial participants and patients interested in research. Find out more and register today: https://lnkd.in/eN8zy2sd #DrugRepurposing #ClinicalTrials #ClinicalStudies

🗞️Our first newsletter for 2025 is out! 🗞️ Some highlights include: 🌟 ICTD 2025 which is taking place in Madrid Spain with our Spanish partners at the Spanish Clinical Research Network (SCReN) 🌟 IHI READI's project launch 🌟 The revised workplan for #ACTEU 🌟 European Medicines Agency supports MACUSTAR .eu 🌟 Horizon Europe open again to Swiss researchers (Swiss Clinical Trial Organisation) Stay up to date ➡️ https://lnkd.in/eAwekbs5 #ClinicalTrials #EuropeanResearch #Newsletter

Thank you to PtCRIN Portuguese Clinical Research Infrastructure Network for hosting such a wonderful event and supporting the national scientific societies. We were honoured to join and contribute to the discussion on how ECRIN facilitates Investigator Initiated Clinical Trial efforts within and beyond the Portuguese borders.

The European public-private partnership consortium MACUSTAR .eu has received a third Letter of Support from the European Medicines Agency (EMA) for its efforts in developing novel outcome measures for clinical trials evaluating treatments for the common eye condition age-related macular degeneration (AMD). 💡 The scientific advice by the agency was based on four-year study results of more than 600 Europeans with early stages of AMD who are at a high risk of developing visual impairment. EMA recognises the high quality and impact of the scientific outputs from the MACUSTAR project that may have impact on more than 200 million patients with AMD globally. Read more ➡️ https://lnkd.in/eiV3xh4h ECRIN is providing services through is partners in Germany (SZB, Universitätsklinikum Bonn), France (FONDATION FORCE POUR L'INNOVATION ET LA RECHERCHE EN SANTE), Italy (CORESEARCH, Center for Outcomes Research and Epidemiology and Clinical Epidemiology S.r.l.), Portugal (NOVA CRU, NOVA Medical School - Faculdade de Ciências Médicas-UNL), Denmark (SMERUD Medical Research Group International AS), The Netherlands (Stichting Radboud Universitair Medisch Centrum), the UK and Ireland (University College Cork – National University of Ireland). Innovative Health Initiative (IHI) #ClinicalStudy #iAMD #Ophthalmology

What a wonderful launch for the IHI READI - Research in Europe and Diversity Inclusion - project in Madrid. ECRIN is thrilled to contribute to this project co-leading the work on protocol design and clinical operations. This ambitious IHI project coordinated by SERMAS & Novartis will endeavour to promote a less fragmented and more democratic ecosystem for clinical studies (CS) by engaging key stakeholders in the process of including underserved and underrepresented populations in CS. Learn more: https://lnkd.in/eNC5YbaV

We’re excited to launch our ‘News from National Partners’ series with a feature on The HRB National Clinical Trials Office (NCTO) - Ireland’s hubfor all things clinical trials and investigations across the Medicines and MedTech sectors 🏥☘️ As a national network, HRB NCTO provides centralised support for multi-centre clinical trials and investigations in the sectors of Medicines and MedTech. Backed by the Health Research Board, Enterprise Ireland, and University College Cork, they work with seven university-based Clinical Research Facilities/Centres to drive patient-focused, world-class research across Ireland. Their mission? To ensure Ireland’s capacity to conduct innovative, high-quality clinical research, benefiting both patients and the Irish economy. Read the full article below & stay tuned - this is just the beginning of a series showcasing inspiring work from our national partners across Europe! 🚀 CZECRIN, F-CRIN, KKS-Netzwerk e. V., HECRIN (Hungarian National Health Research Agency) GreCRIN _ECRIN, ItaCRIN (Istituto Superiore di Sanità), NorCRIN, PCTN (Agencja Badań Medycznych), PtCRIN Portuguese Clinical Research Infrastructure Network, Spanish Clinical Research Network (SCReN), SLOVACRIN, Swiss Clinical Trial Organisation